Michael Hassman

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

C. Mcevoy, A. Falsey, S. Little, 2021, The New England journal of medicine.

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.

J. Oxford, A. Monto, R. Welliver, 2001, JAMA.

OSELTAMIVIR POST EXPOSURE PROPHYLAXIS INVESTIGATOR GROUP. EFFECTIVENESS OF OSELTAMIVIR IN PREVENTING INFLUENZA IN HOUSEHOLD CONTACTS: A RANDOMIZED CONTROLLED TRIAL

A. Monto, R. Welliver, O. Carewicz, 2001 .

Successful Validation of a Wearable, On-body Infusor for Subcutaneous Administration of Furoscix® in Heart Failure Patients, Caregivers, and Health Care Practitioners

A. Andre, Bhavini B. Patel, Matthew M. Goodwin, 2020 .

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

R. Griffiths, B. Dunlop, C. Raison, 2023, JAMA.